DADA is capable of processing the regulatory information contained in the Summary of Products Characteristics and submitting this information to the extended EudraVigilance Medicinal Product Dictionary (XEVMPD) in line with Article 57(2) of the new pharmacovigilance legislation. The experienced team at DADA will conduct several quality checks during the creation of product report messages (XEVPRM) for submission to the XEVMPD and keep you informed of successful population. Maintenance of the XEVMPD will require close and clear communication to ensure timely updating of the submitted information, a trademark of the DADA team.